ETRA Electra Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: not available
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $40.0M | $0 |
| 2026-Q4 | $8.7M | $0 |
Bought$48.7M14 buy days
Sold$00 sell days
Net insider flow+$48.7Mnet buying · 5 years
Latest trade2026-11-10ORBIMED ADVISORS LLC
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-10 | Buy | ORBIMED ADVISORS LLC | Director | 22,700 | $8.45 | $191.8K | 2 |
| 2026-11-10 | Buy | GORDON CARL L | Director | 22,700 | $8.45 | $191.8K | 2 |
| 2026-11-09 | Buy | GORDON CARL L | Director | 20,000 | $8.24 | $164.8K | 2 |
| 2026-11-09 | Buy | ORBIMED ADVISORS LLC | Director | 20,000 | $8.24 | $164.8K | 2 |
| 2026-11-06 | Buy | ORBIMED ADVISORS LLC | Director | 49,416 | $7.85 | $387.9K | 2 |
| 2026-11-06 | Buy | GORDON CARL L | Director | 49,416 | $7.85 | $387.9K | 2 |
| 2026-11-05 | Buy | GORDON CARL L | Director | 156,091 | $7.31 | $1.1M | 2 |
| 2026-11-05 | Buy | ORBIMED ADVISORS LLC | Director | 156,091 | $7.31 | $1.1M | 2 |
| 2026-11-04 | Buy | ORBIMED ADVISORS LLC | Director | 71,367 | $7.53 | $537.5K | 4 |
| 2026-11-04 | Buy | GORDON CARL L | Director | 71,367 | $7.53 | $537.5K | 4 |
| 2026-11-03 | Buy | ORBIMED ADVISORS LLC | Director | 245,113 | $7.86 | $1.9M | 4 |
| 2026-11-03 | Buy | GORDON CARL L | Director | 245,113 | $7.86 | $1.9M | 4 |
| 2026-09-21 | Buy | ORBIMED ADVISORS LLC | Director | 1,333,333 | $15.00 | $20.0M | 2 |
| 2026-09-21 | Buy | GORDON CARL L | Director | 1,333,333 | $15.00 | $20.0M | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| GORDON CARL L | Director | $24.3M | $0 | 2026-11-10 |
| ORBIMED ADVISORS LLC | Director | $24.3M | $0 | 2026-11-10 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.